- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
The Balm of Gilead: Is the Provision of Treatment to those Who Seroconvert in HIV Prevention Trials a Matter of Moral Obligation or Moral Negotiation?
Journal of Law, Medicine and Ethics 34 (4):793-808 (2006)
Abstract
Must treatment be provided to subjects who acquire HIV during the course of a prevention study? An analysis of ethical foundation, regulation, and recent argumentation provides no basis for the obligation. We outline an alternative approach to the problem based on moral negotiationAuthor's Profile
Links
PhilArchive
External links
(no proxy)
Setup an account with your affiliations in order to access resources via your University's proxy server
Through your library
- Sign in / register and customize your OpenURL resolver
- Configure custom resolver
My notes
Similar books and articles
Revisiting the Ethics of HIV Prevention Research in Developing Countries.Charles Weijer & Guy LeBlanc - unknown
Because we can: Clashes of perspective over researcher obligation in the failed prep trials.Bridget G. Haire - 2011 - Developing World Bioethics 11 (2):63-74.
Access to treatment in hiv prevention trials: Perspectives from a south african community.Nicola Barsdorf, Suzanne Maman, Nancy Kass & Catherine Slack - 2009 - Developing World Bioethics 10 (2):78-87.
Conceptualizing a Human Right to Prevention in Global HIV/AIDS Policy.B. M. Meier, K. N. Brugh & Y. Halima - 2012 - Public Health Ethics 5 (3):263-282.
Treatment needs in hiv prevention trials: Using beneficence to clarify sponsor-investigator responsibilities.Melissa Stobie & Catherine Slack - 2010 - Developing World Bioethics 10 (3):150-157.
Impact of Donor-imposed Requirements and Restrictions on Standards of Prevention and Access to Care and Treatment in HIV Prevention Trials.S. Philpott, K. West Slevin, K. Shapiro & L. Heise - 2010 - Public Health Ethics 3 (3):220-228.
Ethical aspects of hiv/aids prevention strategies and control in malawi.Joseph-Matthew Mfutso-Bengo, Eva-Maria Mfutso-Bengo & Francis Masiye - 2008 - Theoretical Medicine and Bioethics 29 (5):349-356.
Intertwining Biomedical Research and Public Health in HIV Microbicide Research.R. Macklin - 2010 - Public Health Ethics 3 (3):199-209.
How Good Is “Good Enough”? The Case for Varying Standards of Evidence According to Need for New Interventions in HIV Prevention.Bridget Haire, John Kaldor & Christopher Fc Jordens - 2012 - American Journal of Bioethics 12 (6):21-30.
Problems With Prioritization: Exploring Ethical Solutions to Inequalities in HIV Care.Kjell Arne Johansson & Ole Frithjof Norheim - 2011 - American Journal of Bioethics 11 (12):32-40.
Bioethics for Clinicians: 16. Dealing with Demands for Inappropriate Treatment.Charles Weijer, Peter A. Singer, Bernard M. Dickens & Stephen Workman - unknown
From pmtct to a more comprehensive aids response for women: A much-needed shift.Cynthia Eyakuze, Debra A. Jones, Ann M. Starrs & Naomi Sorkin - 2008 - Developing World Bioethics 8 (1):33–42.
Mass Testing and Mass Treatment for Epidemic HIV: The Ethics of Medical Research is No Guide.R. Bayer - 2010 - Public Health Ethics 3 (3):301-302.
Analytics
Added to PP
2010-09-08
Downloads
45 (#345,268)
6 months
8 (#342,364)
2010-09-08
Downloads
45 (#345,268)
6 months
8 (#342,364)
Historical graph of downloads
Author's Profile
Citations of this work
Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective.Pamela Andanda & Jane Wathuta - 2018 - Medicine, Health Care and Philosophy 21 (1):139-155.
Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach.Stuart Rennie & Jeremy Sugarman - 2010 - Journal of Medical Ethics 36 (12):810-815.
Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials.Rika Moorhouse, Catherine Slack, Michael Quayle, Zaynab Essack & Graham Lindegger - 2014 - BMC Medical Ethics 15 (1):51.
Engaging Diverse Social and Cultural Worlds: Perspectives on Benefits in International Clinical Research From South African Communities.Olga Zvonareva, Nora Engel, Eleanor Ross, Ron Berghmans, Ames Dhai & Anja Krumeich - 2013 - Developing World Bioethics 15 (1):8-17.
Hiv vaccine trials: Reconsidering the therapeutic misconception and the question of what constitutes trial related injuries.Udo Schüklenk & Richard Ashcroft - 2007 - Developing World Bioethics 7 (3):ii–iv.
References found in this work
When Are Research Risks Reasonable in Relation to Anticipated Benefits?Charles Weijer & Paul B. Miller - unknown
Moral Standards for Research in Developing Countries from "Reasonable Availability" to "Fair Benefits".Maged El Setouhy, Tsiri Agbenyega, Francis Anto, Christine Alexandra Clerk, Kwadwo A. Koram, Michael English, Rashid Juma, Catherine Molyneux, Norbert Peshu, Newton Kumwenda, Joseph Mfutso-Bengu, Malcolm Molyneux, Terrie Taylor, Doumbia Aissata Diarra, Saibou Maiga, Mamadou Sylla, Dione Youssouf, Catherine Olufunke Falade, Segun Gbadegesin, Reidar Lie, Ferdinand Mugusi, David Ngassapa, Julius Ecuru, Ambrose Talisuna, Ezekiel Emanuel, Christine Grady, Elizabeth Higgs, Christopher Plowe, Jeremy Sugarman & David Wendler - 2004 - Hastings Center Report 34 (3):17.
Fiduciary Obligation in Clinical Research.Paul B. Miller & Charles Weijer - 2006 - Journal of Law, Medicine and Ethics 34 (2):424-440.
Protecting Communities in Research: Philosophical and Pragmatic Challenges.Charles Weijer - 1999 - Cambridge Quarterly of Healthcare Ethics 8 (4):501-513.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-7c76586df8-hc2g5 uwo